These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1620208)

  • 41. How the environment affects research on prenatal drug exposure: the laboratory and the community.
    Coles CD
    NIDA Res Monogr; 1992; 117():271-92. PubMed ID: 1620202
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transient pathological cardiotocography secondary to maternal drug abuse.
    Elkington NM; Mills M; Soothill P
    J Obstet Gynaecol; 2004 Feb; 24(2):182-3. PubMed ID: 14766466
    [No Abstract]   [Full Text] [Related]  

  • 43. Discussion: research environment and use of multicenter studies in perinatal substance abuse research.
    Rich KC
    NIDA Res Monogr; 1992; 117():293-304. PubMed ID: 1620203
    [No Abstract]   [Full Text] [Related]  

  • 44. Detection of prenatal drug exposure in the pregnant woman and her newborn infant.
    Ostrea EM
    NIDA Res Monogr; 1992; 117():61-79. PubMed ID: 1620211
    [No Abstract]   [Full Text] [Related]  

  • 45. Maternal drug abuse and ocular morbidity: more than meets the eye?
    Nischal KK
    Br J Ophthalmol; 2010 Jun; 94(6):671. PubMed ID: 20508041
    [No Abstract]   [Full Text] [Related]  

  • 46. Substance abuse in pregnant women: making improved detection a good clinical outcome.
    Araojo R; McCune S; Feibus K
    Clin Pharmacol Ther; 2008 Apr; 83(4):520-2. PubMed ID: 18349872
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Statement on drug use in pregnancy: an urgent problem for New York City. Committee on Public Health. The New York Academy of Medicine.
    Bull N Y Acad Med; 1990; 66(2):193-7. PubMed ID: 2364214
    [No Abstract]   [Full Text] [Related]  

  • 48. Whitner v. State: aberrational judicial response or wave of the future for maternal substance abuse cases?
    Coffey C
    J Contemp Health Law Policy; 1997; 14(1):211-51. PubMed ID: 9458615
    [No Abstract]   [Full Text] [Related]  

  • 49. Methodological issues in prevention research on drug use and pregnancy.
    Gilchrist LD; Gillmore MR
    NIDA Res Monogr; 1992; 117():1-17. PubMed ID: 1620189
    [No Abstract]   [Full Text] [Related]  

  • 50. Discussion: subject selection, recruitment, and retention in longitudinal studies involving perinatal substance abuse and human immunodeficiency virus infection.
    Bandstra ES
    NIDA Res Monogr; 1992; 117():183-93. PubMed ID: 1620196
    [No Abstract]   [Full Text] [Related]  

  • 51. The forensic pathology of drug-related child abuse.
    Densen-Gerber J
    Leg Med Annu; 1978; ():135-47. PubMed ID: 756933
    [No Abstract]   [Full Text] [Related]  

  • 52. Cocaine, pregnancy, and the growing child.
    Chasnoff IJ
    Curr Probl Pediatr; 1992 Aug; 22(7):302-21; discussion 322. PubMed ID: 1395712
    [No Abstract]   [Full Text] [Related]  

  • 53. Maternal drug abuse and its effects on young children.
    Lewis KD; Schmeder NH; Bennett B
    MCN Am J Matern Child Nurs; 1992; 17(4):198-203. PubMed ID: 1635432
    [No Abstract]   [Full Text] [Related]  

  • 54. [How do we solve the conflict of interest between the pregnant woman and her fetus?].
    Tännsjö T
    Lakartidningen; 1992 Sep; 89(40):3299-300. PubMed ID: 1405949
    [No Abstract]   [Full Text] [Related]  

  • 55. Alcohol- and drug-dependent pregnant women: laws and public policies that promote and inhibit research and the delivery of services.
    Weber EM
    NIDA Res Monogr; 1992; 117():349-65. PubMed ID: 1620207
    [No Abstract]   [Full Text] [Related]  

  • 56. Long-term psychoeducational outcome of prenatal substance exposure.
    Scott KG; Urbano JC; Boussy CA
    Semin Perinatol; 1991 Aug; 15(4):317-23. PubMed ID: 1948143
    [No Abstract]   [Full Text] [Related]  

  • 57. Prenatal cocaine exposure.
    Fantel AG; Shepard TH
    Reprod Toxicol; 1990; 4(2):83. PubMed ID: 2136031
    [No Abstract]   [Full Text] [Related]  

  • 58. Discussion: dilemmas in research in perinatal addiction--intervention issues.
    Finnegan LP
    NIDA Res Monogr; 1992; 117():344-8. PubMed ID: 1620206
    [No Abstract]   [Full Text] [Related]  

  • 59. Introduction to "Understanding developmental consequences of prenatal drug exposure: Biological and environmental effects and their interactions".
    Singer LT; Richardson GA
    Neurotoxicol Teratol; 2011; 33(1):5-8. PubMed ID: 21047553
    [No Abstract]   [Full Text] [Related]  

  • 60. Subject recruitment and retention for longitudinal research: practical considerations for a nonintervention model.
    Streissguth AP; Guinta CT
    NIDA Res Monogr; 1992; 117():137-54. PubMed ID: 1620192
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.